Gopikasree Gunasegaran , Sasan Moghimi , Evan Walker , Takashi Nishida , Jeffrey M. Liebmann , Massimo A. Fazio , Christopher A. Girkin , Linda M. Zangwill , Robert N. Weinreb
{"title":"Differential Impact of Central and Global Visual Field Progression on Quality of Life in Glaucoma","authors":"Gopikasree Gunasegaran , Sasan Moghimi , Evan Walker , Takashi Nishida , Jeffrey M. Liebmann , Massimo A. Fazio , Christopher A. Girkin , Linda M. Zangwill , Robert N. Weinreb","doi":"10.1016/j.ajo.2025.04.031","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>To determine the impact of progression of central visual field (VF) and global VF on vision-related quality of life (VRQOL).</div></div><div><h3>Design</h3><div>Retrospective cohort study.</div></div><div><h3>Methods</h3><div>This study included 364 eyes of 235 primary open-angle glaucoma participants who had at least five 24-2 VF tests over a minimum of 2-year follow-up. The slopes of global mean deviation (MD) and central mean total deviation (MTD<sub>10</sub>) (12 test points within the central 10° of 24-2) were calculated. Analyses were conducted using different slope thresholds to define VF-based progression, and mean composite National Eye Institute Visual Function Questionnaire Rasch-calibrated scores associated with these progression thresholds were quantified using linear mixed-effects models.</div></div><div><h3>Results</h3><div>The baseline 24-2 VF MD of all participants was –5.6 (95% CI –6.4, –4.9) decibels (dB). At baseline, eyes with MTD<sub>10</sub> progression had significantly worse 24-2 VF MD compared to those without MTD<sub>10</sub> progression. When fast progression was defined as MTD<sub>10</sub> slope <–0.50 dB/y, fast progressors had a mean baseline 24-2 MD of –9.71 dB (95% CI –11.89, –7.53) compared to –5.24 dB (95% CI –6.02, –4.46) in slow progressors (<em>P</em> < .001). Eyes exhibiting MTD<sub>10</sub> progression consistently displayed worse mean composite VRQOL scores across various thresholds compared to global MD. Notably, a similar level of VRQOL impairment was observed at a lower threshold for MTD<sub>10</sub> compared to MD, consistent across all glaucoma severity groups. In the overall cohort, eyes progressing at a rate of –0.5 dB/y or faster for MTD<sub>10</sub> had a mean composite VRQOL score comparable to those progressing at –1.0 dB/y or faster for global MD.</div></div><div><h3>Conclusions</h3><div>Central VF change had a greater impact on VRQOL compared to global VF change. Conventional assessments based on global MD may underestimate the effect of central VF changes. Refining progression detection strategies to include central VF is necessary to better reflect changes in patient-centered outcomes like VRQOL.</div></div>","PeriodicalId":7568,"journal":{"name":"American Journal of Ophthalmology","volume":"276 ","pages":"Pages 327-335"},"PeriodicalIF":4.1000,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S000293942500217X","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
To determine the impact of progression of central visual field (VF) and global VF on vision-related quality of life (VRQOL).
Design
Retrospective cohort study.
Methods
This study included 364 eyes of 235 primary open-angle glaucoma participants who had at least five 24-2 VF tests over a minimum of 2-year follow-up. The slopes of global mean deviation (MD) and central mean total deviation (MTD10) (12 test points within the central 10° of 24-2) were calculated. Analyses were conducted using different slope thresholds to define VF-based progression, and mean composite National Eye Institute Visual Function Questionnaire Rasch-calibrated scores associated with these progression thresholds were quantified using linear mixed-effects models.
Results
The baseline 24-2 VF MD of all participants was –5.6 (95% CI –6.4, –4.9) decibels (dB). At baseline, eyes with MTD10 progression had significantly worse 24-2 VF MD compared to those without MTD10 progression. When fast progression was defined as MTD10 slope <–0.50 dB/y, fast progressors had a mean baseline 24-2 MD of –9.71 dB (95% CI –11.89, –7.53) compared to –5.24 dB (95% CI –6.02, –4.46) in slow progressors (P < .001). Eyes exhibiting MTD10 progression consistently displayed worse mean composite VRQOL scores across various thresholds compared to global MD. Notably, a similar level of VRQOL impairment was observed at a lower threshold for MTD10 compared to MD, consistent across all glaucoma severity groups. In the overall cohort, eyes progressing at a rate of –0.5 dB/y or faster for MTD10 had a mean composite VRQOL score comparable to those progressing at –1.0 dB/y or faster for global MD.
Conclusions
Central VF change had a greater impact on VRQOL compared to global VF change. Conventional assessments based on global MD may underestimate the effect of central VF changes. Refining progression detection strategies to include central VF is necessary to better reflect changes in patient-centered outcomes like VRQOL.
期刊介绍:
The American Journal of Ophthalmology is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and visual science specialists describing clinical investigations, clinical observations, and clinically relevant laboratory investigations. Published monthly since 1884, the full text of the American Journal of Ophthalmology and supplementary material are also presented online at www.AJO.com and on ScienceDirect.
The American Journal of Ophthalmology publishes Full-Length Articles, Perspectives, Editorials, Correspondences, Books Reports and Announcements. Brief Reports and Case Reports are no longer published. We recommend submitting Brief Reports and Case Reports to our companion publication, the American Journal of Ophthalmology Case Reports.
Manuscripts are accepted with the understanding that they have not been and will not be published elsewhere substantially in any format, and that there are no ethical problems with the content or data collection. Authors may be requested to produce the data upon which the manuscript is based and to answer expeditiously any questions about the manuscript or its authors.